Leadership Shift A leadership change in 2021 suggests potential strategic shifts; pursue conversations with PCG's leadership to explore joint research programs, sponsored studies, and expansion of the proton therapy registry.

Proton Therapy Focus PCG’s core mission centers on advanced particle radiotherapy and a comprehensive proton therapy registry, creating opportunities for data analytics, registry management software, and secure data exchange solutions for researchers and clinicians.

Tech Modernization The current tech stack relies on WordPress and common web tools; present modern, compliant cloud hosting, data integration, and analytics platforms to strengthen registry operations and researcher collaboration while ensuring security and HIPAA readiness.

Scale Ready With a small team and modest revenue, PCG is well-positioned to partner on cost-effective, managed services such as CRM integration, marketing automation, grant management, and outsourced data management to accelerate growth without large upfront investments.

Strategic Differentiator To stand out against larger competitors, PCG could leverage a differentiated registry platform with interoperability and rapid network expansion to attract mid-sized cancer centers and research institutions seeking faster access to collaborative research opportunities.